Messenger Biopharma
|
Year Established:
2015 |
|
|
Website:
messengerbiopharma.com |
|
|
Headquarters:
Riom, Auvergne-Rhône-Alpes, FR |
|
|
Company Type:
New Startup (0-1M TTM Revenue) |
|
|
Open Requests:
1 |
|
Certifications:
|
Messenger Biopharma is a biotech company dedicated to research on messenger RNA (mRNA) design and in vivo delivery to human and animal tissues.
Our patented Aegis biotechnology is about an uncapped mRNA that is 30 times cheaper to synthesize than any conventional capped mRNA. Furthermore, the transfection of our uncapped mRNA to mouse skin and skeletal muscle leads to reporter protein expression levels up to 10 times higher than those achieved with any classical capped mRNA.
Messenger Biopharma is currently working on an innovation regarding the improvement of mRNA uptake in mouse tissues.
We propose to sell you our proprietary mRNA coding your protein of interest to test and/or compare it with your current mRNA.
We also wish to out-license our Aegis biotechnology to pharmaceutical companies, which develop mRNA-based drugs and vaccines.
| Site | Badges | |
|---|---|---|
| Messenger Biopharma 22 rue Henri et Gilberte Goudier Riom, Auvergne-Rhône-Alpes, 63200 France | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.